TheEdgeResearch
Home / Stocks / BARK

BARK, Inc. (BARK)

NYSE Consumer Cyclical Specialty Retail
$10.86 ▲ +1.26%
Market Cap
$98.1M
Sector
Consumer Cyclical
Industry
Specialty Retail
Beta
1.95
52-Wk Range
8.15-20.8
CEO
Matt Meeker
Country
US
Currency
USD

BARK, Inc. operates in the Specialty Retail industry of the Consumer Cyclical sector, headquartered in Brooklyn, NY, US. The stock last traded at $10.86, up 1.26% on the session, giving a market capitalisation of $98.1M. On trailing twelve-month figures it carries a trailing P/E of -3.01, a net margin of -8.4%. Its beta of 1.95 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-3.01
Price / Sales
0.26
Price / Book
1.23
EV / EBITDA
-5.03
Gross margin
63.4%
Operating margin
-8.6%
Net margin
-8.4%
Return on equity
Debt / equity
0.48
Current ratio
2.02
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange
Employees
501
IPO date
2020-12-18
Headquarters
Brooklyn, NY, US
About BARK, Inc.

BARK, Inc., a dog-centric company, provides products, services, and content for dogs. The company operates in two segments, Direct to Consumer and Commerce. It provides subscription products, including monthly themed boxes of toys and treats to a dog’s home, as well as kibble, treats, chews, toothpastes, sprinkles, broths, bites, hip and joint support products, skin and coat support products, beds, leashes, apparel, and other accessories and products under the BarkBox, Super Chewer, and BARK Bright names. The company also offers air travel experience to dogs under the BARK Air name. The company sells its products through a network of retail partners, as well as directly to consumers. BARK, Inc. was founded in 2011 and is headquartered in New York, New York.

Comparable companies

BARK, Inc. is most often compared with the following Consumer Cyclical names:

AIIOAKABZUNDIBSFFAIGDHGLAKENPTPLCESPWH
More research on BARK
BARK technical analysis BARK TheEdge Score Compare against peers
Open full interactive analysis & DCF →